An extract of an herbal composition comprising at least two different dried plants useful as antimicrobial and/or antibiofilm agent in the treatment or prevention of microbial infections caused by bacteria, such as for example Escherichia, Klebsiella, Listeria, Pseudomonas, Salmonella, Streptococcus or Staphylococcus, or by fungi, such as for example is herein described. It has been found that in such extract, the active ingredients exert their biological effects in a synergistic manner. The extract may constitute the active ingredient of a food supplement, a nutraceutical, pharmaceutical or cosmetic composition or a functional food or a food additive. A process for preparing said extract is also described here.

The methods disclosed herein permit the synthesis of cannabinoid-containing oral thin film (OTF) strips that also contain caffeine or multiple additional active ingredients. Selection of film forming agents based on water usage coupled with low temperature mixing and low temperature drying may in various embodiments permit the incorporation of up to five additional ingredients into a cannabinoid containing OTF product.

The methods disclosed herein permit the synthesis of cannabinoid-containing oral thin film (OTF) strips that also contain caffeine or multiple additional active ingredients. Selection of film forming agents based on water usage coupled with low temperature mixing and low temperature drying may in various embodiments permit the incorporation of up to five additional ingredients into a cannabinoid containing OTF product.

A composition suitable for providing living organisms enhanced rest, recovery and sleep is presented. The composition includes Ashwagandha. The composition also includes LuteMax. The composition further includes Clock. The composition includes Lemon Balm. The composition also includes Lotus Leaf. The composition further includes Valerian Root. A method for producing a composition is also presented. The method adjusts dosages of the ingredients based on an age bracket, gender, stress level a soundness of sleep the person typically has a level of gastric health of the person wherein the dosages chosen by the method include interaction between the person and an online website to determine appropriate dosages.

A composition suitable for providing living organisms enhanced rest, recovery and sleep is presented. The composition includes Ashwagandha. The composition also includes LuteMax. The composition further includes Clock. The composition includes Lemon Balm. The composition also includes Lotus Leaf. The composition further includes Valerian Root. A method for producing a composition is also presented. The method adjusts dosages of the ingredients based on an age bracket, gender, stress level a soundness of sleep the person typically has a level of gastric health of the person wherein the dosages chosen by the method include interaction between the person and an online website to determine appropriate dosages.

A composition suitable for providing living organisms enhanced rest, recovery and sleep is presented. The composition includes Ashwagandha. The composition also includes LuteMax. The composition further includes Clock. The composition includes Lemon Balm. The composition also includes Lotus Leaf. The composition further includes Valerian Root. A method for producing a composition is also presented. The method adjusts dosages of the ingredients based on an age bracket, gender, stress level a soundness of sleep the person typically has a level of gastric health of the person wherein the dosages chosen by the method include interaction between the person and an online website to determine appropriate dosages.

Various embodiments relate to bioactive compositions, including a first component including 1 to 300 mg/dose of a psychotropic cannabinoid, a non-psychotropic cannabinoid, or a mixture thereof; a second component including 1 to 400 mg/dose of a methylxanthine; and an aqueous carrier.

Various embodiments relate to bioactive compositions, including a first component including 1 to 300 mg/dose of a psychotropic cannabinoid, a non-psychotropic cannabinoid, or a mixture thereof; a second component including 1 to 400 mg/dose of a methylxanthine; and an aqueous carrier.

The present description relates to an anti-aging composition comprising at least one plant extract. The composition can comprise at least two different anti-aging agents, wherein one the anti-aging agent is a plant extract. The combination of two anti-aging agents has a superior effect on regulating longevity compared to the use of one anti-aging agent. The plant extract is preferably selected from the group consisting of a Black cohosh extract, a Valerian extract, a Ginkgo biloba extract, a Celery seed extract, a White willow extract and a Passion flower extract.

The present description relates to an anti-aging composition comprising at least one plant extract. The composition can comprise at least two different anti-aging agents, wherein one the anti-aging agent is a plant extract. The combination of two anti-aging agents has a superior effect on regulating longevity compared to the use of one anti-aging agent. The plant extract is preferably selected from the group consisting of a Black cohosh extract, a Valerian extract, a Ginkgo biloba extract, a Celery seed extract, a White willow extract and a Passion flower extract.